pdf

O’Melveny’s Representation of Investors in Series A Financing Featured in IP Frontline

July 20, 2012

O’Melveny & Myers LLP’s representation of Palo Alto Investors and Sofinnova Ventures in their co-investment with New Enterprise Associates in the US$40 million Series A Convertible Preferred Stock financing of Alimera Sciences was featured in the July 20, 2012, IP Frontline deal briefing. The O'Melveny deal team was led by partners Paul Scrivano and Brian Covotta, counsel Jeff Cislini, and associate Noah Kornblith.